Episode 41: Fat Loss Agents for the Enhanced Competitor
In this episode of J3 University, Luke and I discuss fat loss agent deployment in enhancedcompetition. We cover each potential compound that is an option…
Episode 40: Getting Too Fat? Lets Mini-Cut!
In this episode of J3 University, Luke and I discuss the ins and outs of implementing mini cuts. Often wesee offseason get into subpar territory…
Episode 39: IFBB Pro Cory Hageman: Challenges of Bikini
In this episode of J3 University, Luke and I are joined by IFBB Pro Cory Hageman to discuss her journeythrough the bikini ranks. Cory has…
Episode 38: What is a “Gaintain” Phase?
In this episode of J3 University, Luke and I discuss the transition phases betweenmuscle accrual and fat loss phases. The “gaintain” or holding phase is…
Episode 37: Prophylactic Series: Why Insulin in Enhanced Competitors?
TimestampsInsulin Function and Basic Physiology- 00:00:57What leads to insulin sensitivity? – 00:03:28Classes of Insulin- 00:13:37When to deploy insulin- 00:21:54Will Insulin therapy cause your pancreas to…
Episode 36: Victoria Felkar: Optimizing Female Hormones and Deploying PEDs
In this episode of J3 University, Luke and I are joined by Victoria Felkar, PhD(c) todiscuss female PED use in physique competition. The conversation starts…
Episode 35: Prophylactic Series: Why Metformin in Enhanced Competitors?
In this episode of J3 University, Luke and I discuss the risk of PED usage and howMetformin might serve as a harm reduction strategy. When…